We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sdi Group Plc | LSE:SDI | London | Ordinary Share | GB00B3FBWW43 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.50 | 3.62% | 71.50 | 71.00 | 72.00 | 74.00 | 69.50 | 69.50 | 1,046,525 | 15:22:26 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 67.58M | 3.87M | 0.0372 | 19.22 | 74.4M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/6/2013 21:45 | Well Nigel, I guess mkt expectations are in line with the house broker as below FinnCap 20-06-13 CORP pre tax 0.20 eps3.80 - 0.40 4.80 Fwd PER of 6 and falling! May be of interest. hxxp://www.cambridge | hastings | |
21/6/2013 13:39 | A disappointingly deep discount for the placing. Results to be "in line with market expectations", which is one of my pet hates. If, for whatever reason, they do not say what "market expectations" are then they should not be allowed to say they expect to meet market expectations. Nigel Martin Edit: on reading further, they were rather over a barrel, needing to raise the money to pay off the convertible at the end of July. | gnnmartin | |
21/6/2013 13:19 | Equity issue and trading update - see the RNS. | nick2008 | |
17/4/2013 22:21 | Enjoyed a good run Nick and hopefully continue that way. | hastings | |
17/4/2013 21:42 | This has held its price steady. This month marks the end of trading year. Let's hope for trading update early next month. Nick. | nick2008 | |
18/3/2013 19:01 | Buying continues @27p...... | nick2008 | |
15/3/2013 18:13 | Some good buying through in the last few days. MMs will be short at this rate......Nick | nick2008 | |
08/3/2013 10:15 | Nick2008 7 Feb'13 - 13:36 - 19 of 28 0 0 edit For me, the best sales initiative for their new product ProReveal is to appoint Peskett Solutions Ltd as the sole UK Distributor. ProReveal product is 100 times more senstive than the current tests, so I'm sure RUHOF would have heard about it through their own UK Distributor - Peskett Solutions. There is no conflict of interest between RUHOF & SDI. RUHOF's product is used for cleaning the instruments and SDI detects the protein on them after cleaning. If the cleaning is below a certain threshold, then all the instruments have to be cleaned again using RUHOF cleaning product. RUHOF is large organisation with worldwide dealers and distribution centres. I won't surprised if RUHOF themselves would be keen to sell SDI products outside UK, using their own channels.... Evidence that RUHOF themselves are keen to sell SDI products outside UK, using their own channels - 1. See the report presentation from Dr.N.K.Nayuni - one the scientists who invented the ProReveal detection - to Ruhuf. Pls have a look at appendix B for reference of ProReveal 2. SDI patent link show the inventors including Dr.N.K.Nayuni. Inventor(s) list and link PERRETT, David NAYUNI, Nanda Kishore; ELLWOOD, Paul; MASKELL, Richard; WRIGHT, Alastair Hayden; THOMPSON, Sarah; SULLIVAN, Laura; Note that one of inventor is Paul Ellwood, the CEO of Synoptics - One of subsidiary of SDI. | nick2008 | |
27/2/2013 13:50 | Nice spot Nick. | hastings | |
26/2/2013 14:01 | Another article highlighting that existing methods of detecting proteins on the surgical instruments are ineffective and that this will be changed in the NHS guidelines as well. SDI uses the new 'to be recommended' NHS guidelines to detect proteins - Detection using fluorescence The problem of protein: how clean is 'clean'? - Feb 2013 The above article makes reference to ProReveal - the SDI detection tool which was launched in Dec-2012. | nick2008 | |
23/2/2013 15:41 | Slow and steady rise here. Another 10% up. From Dec 2012 it was 11p to now 26p. 136% rise. More to come.... | nick2008 | |
12/2/2013 11:56 | In Dec-12, Synoptics Health launch the ProReveal (See header for details), then we saw Artemis (another SDI subsidiary ) launching 11 megapixel CCD () Well! It seems they are launching more new products - See the news below - this time from their Syngene subsidiary . Seems like the new CEO is really making his presence felt. Syngene Launches PXi Touch Range of Versatile Image Analysis Systems publication date: Jan 28, 2013 Related article - Gel Documentation Systems Grow More Sophisticated Tuesday, December 18, 2012 Gel documentation systems might not warrant the ooohs and aaahs of, say, a synchrotron. But gel documentation systems, also called gel imaging systems, are relied upon by vastly more researchers and play a pivotal role in more research projects than the noble synchrotron. The ultimate form of ease of use is automation, which is where many gel documentation systems are headed today. For example, Syngene offers a new line of smaller, more compact gel documentation systems called PXi. Along with Syngene's gel imagers comes the devices' acquisition software, GeneSys. This is the brain that runs the automated tasks for you. "Before this program, users needed to know exactly how to image their sample-including exposure time, light settings, filter settings, camera settings-in order to get the best image," says Maggie Pochyla, U.S. market manager for Syngene. "GeneSys eliminates that need and automatically captures an image perfectly, even if the user is unaware of what lights, filters and exposure time to use." Such a system is especially useful in labs with younger students. The image acquisition and analysis software should be intuitive and easy to use so that even if [users have] no prior imaging experience, they can easily operate the software and system," she says. Syngene's G:BOX and PXi gel documentation systems include automation of the camera and hardware controls | nick2008 | |
11/2/2013 12:36 | Still off the radar for many. | hastings | |
11/2/2013 12:33 | That's some buying going on ! Like everyone's woken up to Fridays RNS just now...... | nick2008 | |
08/2/2013 09:52 | Synbiosis division - one which won this contract - is expected to grow significantly this year. If this starts to contribute as much as the largest division syngene, then we are talking about better than expected profits this year..... Synbiosis from Post 5 - First on the market to generate antibiotic and vaccine potency analysis automatically from count and zone data providing a distinct competitive advantage. - Like the Syngene market space, the trend is to purchase low-cost products, so they have both low entry and high end products available. - Their high end-colony counter and zone sizing system ProtoCOL 3 has been introduced this year and is modular, so offers a cost-effective purchase to customers. - Last year received their single largest order since inception to install 27 ProtoCOL 3 systems on behalf of UNICEF. | nick2008 | |
08/2/2013 07:49 | Commenting on the news SDI's Chairman, Ken Ford, stated: "Selling the ProtoCOL 3 systems to the Chinese equivalent of the FDA is a coup. Our technology was in a rigorous tender process against systems from 10 other US, European and Chinese companies so to come out on top is a boost, not just for our Synbiosis Division, but also for other life science firms in Cambridge's Innovation hub." SDI product & technology better than most other across continents - and with new CEO it's all happening for this stock this year. | nick2008 | |
08/2/2013 07:42 | Wake up Guys, RNS out for sales to Chinese Govt Nick | nick2008 | |
07/2/2013 13:36 | Indeed, Hasting For me, the best sales initiative for their new product ProReveal is to appoint Peskett Solutions Ltd as the sole UK Distributor. - Peskett Solutions currently are the sole UK distributor for world market leader company RUHOF whose cleaning liquid is used in almost all sterile services departments within UK hospitals and globally. - Peskett Solutions are best placed to sell the Synoptics protein detection equipment due to their current product range as they have access to the hospital managers within sterile services departments. - These managers not only just recommend a product but also have the budgets allocated to buy the products and services appropriate to their departments. ProReveal product is 100 times more senstive than the current tests, so I'm sure RUHOF would have heard about it through their own UK Distributor - Peskett Solutions. There is no conflict of interest between RUHOF & SDI. RUHOF's product is used for cleaning the instruments and SDI detects the protein on them after cleaning. If the cleaning is below a certain threshold, then all the instruments have to be cleaned again using RUHOF cleaning product. RUHOF is large organisation with worldwide dealers and distribution centres. I won't surprised if RUHOF themselves would be keen to sell SDI products outside UK, using their own channels.... Nick | nick2008 | |
07/2/2013 12:40 | Yes Nick, i think you will find that those shares were placed in good hands. | hastings | |
07/2/2013 10:27 | Started a New Thread | nick2008 | |
07/2/2013 10:24 | Started a New Thread | nick2008 | |
07/2/2013 10:07 | Hastings Yeap! noted the Non exec Director is an ex Dialight and bought stock twice last year! House broker target is conservative as mgt haven't' revised it yet for revenues from their new first mover competitive advantage product - ProReveal. Once they get a 'feel' for the demand, the forecast and target will be revised north of 40p. Someone I know reckons this will be £4 within 3-4 years! DYOR, Nick | nick2008 | |
06/2/2013 19:35 | Hi Nick, an interesting off the radar Company. FLoated back in 2008 at what was probably not the best of timing! Some interesting Institutions including the BP Pension Fund took a punt and very little happened. However, things stirring here and with a very, very small shareholder base,coupled with limited shares in issue, any real growth in profits will translate into serious Eps appreciation. Non exec Director an ex Dialight and quite shrewd player bought shares prior to the recent spike, but could be a lot more to come. House Broker has a 40p target price for anyone interested. | hastings | |
06/2/2013 15:56 | 26,070 Buys vs 3,821 sells as of now.... | nick2008 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions